Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Pathophysiology/Complications

How Reliable Is Estimation of Glomerular Filtration Rate at Diagnosis of Type 2 Diabetes?

  1. Richard A. Chudleigh, MRCP,
  2. Gareth Dunseath, MPHIL,
  3. William Evans, PHD,
  4. John N. Harvey, MD, FRCP,
  5. Philip Evans, MD, FRCP,
  6. Richard Ollerton, PHD and
  7. David R. Owens, MD, FRCP
  1. From the Diabetes Research Unit, Llandough Hospital, Cardiff, U.K.
  1. Address correspondence and reprint requests to Richard A. Chudleigh, Llandough Hospital, Diabetes Research Unit, Penlan Road Penarth, Cardiff CF64 2XX. E-mail: rachudleigh{at}hotmail.com
Diabetes Care 2007 Feb; 30(2): 300-305. https://doi.org/10.2337/dc06-1688
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Figure 1—
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1—

    Relation of CG- and MDRD-calculated eGFR with 51Cr-EDTA–measured iGFR. The solid line represents the regression line, and the dotted lines represent 95% prediction intervals for iGFR based on eGFR.

Tables

  • Figures
  • Table 1—

    Demographic data

    All subjectsGroup 1 (iGFR <90)Group 2 (iGFR ≥90)
    n29237255
    Men/women219/7325/12194/61
    Age (years)55.3 ± 9.462.8 ± 6.454.2 ± 9.3*
    Weight (kg)92.0 ± 1788.0 ± 16.792.5 ± 17.0
    BMI (kg/m2)31.5 ± 5.630.9 ± 6.031.6 ± 5.5
    A1C (%)7.79 ± 2.007.16 ± 1.837.88 ± 2.01*
    Fasting plasma glucose (mmol/l)9.70 ± 3.098.44 ± 2.499.87 ± 3.13*
    Creatinine (μmol/l)79.9 ± 14.890.7 ± 16.178.4 ± 14.0*
    Systolic blood pressure (mmHg)136 ± 20144 ± 22135 ± 19*
    Diastolic blood pressure (mmHg)81 ± 1080 ± 1082 ± 10
    • Data are means ± SD.

    • *

      ↵* P < 0.05 for difference between means of group 1 and group 2.

  • Table 2—

    Predictive performance of the CG and the MDRD formulae

    iGFR [median (interquartile range)]All subjects (n = 292)
    Group 1 (iGFR <90; n = 37)
    Group 2 (iGFR ≥90; n = 255)
    114.9 (22.4)
    83.8 (4.3); 84 (81–88)
    119.4 (20.3); 115 (103–133)
    FormulaCGMDRDCGMDRDCGMDRD
    eGFR [median (interquartile range)]101.1 (26.8)89.9 (19.0)78.0 (16.5); 76 (69–88.5)73.7 (12.0); 73 (64–82)104.4 (26.3); 100 (87–120)92.3 (18.7); 89 (78–103)
    Bias−13.8 (−16.1 to −11.6)−25.0 (−26.9 to −23.1)−5.8 (−11.1 to −0.6)−10.7 (−14.4 to −7.0)−15.0 (−17.4 to −12.5)−27.1 (−29.1 to −25.1)
    Precision19.516.615.711.219.716.2
    95% limits of agreement(−52.8 to 25.2)(−58.2 to 8.2)(−37.2 to 25.6)(−33.1 to 11.7)(−54.4 to 24.4)(−59.5 to 5.3)
    Accuracy 10%29% (24–35)15% (11–19)32% (19–50)27% (14–44)29% (23–35)13% (9–18)
    Accuracy 30%86% (81–89)79% (74–83)86% (17–95)95% (80–99)85% (80–89)76% (71–81)
    R20.4900.4760.093*0.1190.4500.429
    Gradient0.59 (0.52–0.65)0.81 (0.71–0.91)0.08 (−0.01 to 0.17)0.13 (0.01–0.24)0.52 (0.45–0.59)0.71 (0.61–0.81)
    Intercept55.7 (48.5–63.0)41.9 (32.9–51.0)77.6 (70.8–84.4)74.7 (66.1–83.3)65.6 (57.9–73.2)53.8 (44.2–63.3)
    • Data are means ± SD (95% CI), unless otherwise indicated. All R values were positive and, with one exception

    • *

      ↵* , significantly different from zero.

  • Table 3—

    U.K. CKD staging of subjects in groups 1 and 2

    CG eGFRκ = 0.24
    MDRD eGFRκ = 0.15
    U.K. CKD stage 3 (GFR <60)U.K. CKD stage 2 (GFR 60–89)U.K. CKD stage 1 (GFR ≥90)U.K. CKD stage 3 (GFR <60)U.K. CKD stage 2 (GFR 60–89)U.K. CKD stage 1 (GFR ≥90)
    n61001867156129
    Group 1 (GFR 60–89; n = 37)5/37 (14)24/37 (65)8/37 (21)5/37 (14)29/37 (78)3/37 (8)
    Group 2 (GFR ≥90; n = 255)1/255 (1)76/255 (30)178/255 (69)2/255 (1)127/255 (50)126/255 (49)
    • Data are n (%).

PreviousNext
Back to top
Diabetes Care: 30 (2)

In this Issue

February 2007, 30(2)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
How Reliable Is Estimation of Glomerular Filtration Rate at Diagnosis of Type 2 Diabetes?
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
How Reliable Is Estimation of Glomerular Filtration Rate at Diagnosis of Type 2 Diabetes?
Richard A. Chudleigh, Gareth Dunseath, William Evans, John N. Harvey, Philip Evans, Richard Ollerton, David R. Owens
Diabetes Care Feb 2007, 30 (2) 300-305; DOI: 10.2337/dc06-1688

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

How Reliable Is Estimation of Glomerular Filtration Rate at Diagnosis of Type 2 Diabetes?
Richard A. Chudleigh, Gareth Dunseath, William Evans, John N. Harvey, Philip Evans, Richard Ollerton, David R. Owens
Diabetes Care Feb 2007, 30 (2) 300-305; DOI: 10.2337/dc06-1688
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS—
    • RESULTS—
    • CONCLUSIONS—
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET Cohort
  • Gluconeogenesis, But Not Glycogenolysis, Contributes to the Increase in Endogenous Glucose Production by SGLT-2 Inhibition
  • Day-to-Day Variations in Fasting Plasma Glucose Do Not Influence Gastric Emptying in Subjects With Type 1 Diabetes
Show more Pathophysiology/Complications

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.